Fritextsökning
Innehållstyper
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Hur allvarliga är ”Spermageddon”-rapporterna? – Forskare vill se åtgärder
En uppmärksammad metastudie tyder på att koncentrationen av spermier i mäns sädesvätska halverats på 40 år. Experter på andrologi som Life Science Sweden talar ...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Nya datum för spännande event
The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability flyttas fram till september.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Namn på ersättningsläkemedel kan förvirra
Ersättningsmediciner är bra för landstingens ekonomi. Men samtidigt riskerar patienter att inte känna igen sina mediciner, när det står andra namn på förpacknin...
-
Relax at the After Fair
Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen a...
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Jubileum när life science-kongress hålls för tionde gången
The Future of Swedish and Danish Life Science går in på sitt tionde år som en länk mellan svensk och dansk life science när kongressen hålls efter sommaren. Så här började det.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Studie: Enkel dos antibiotika kan förhindra var tredje fall av sepsis vid förlossning
En enda dos antibiotika minskar kraftigt risken för sepsis under förlossning och kan därmed rädda miljontals kvinnor i låg- och medelinkomstländer från att drab...
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Tar in 250 miljoner
- Klinisk utveckling i sen fas kostar mycket pengar och därför väljer vi att noteras just nu, säger Peter Zerhouni, vd på Index Pharmaceuticals som genomför en ...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.